Multimodality in imaging calcific constrictive pericarditis

Por Langer, C, Butz, T, Horstkotte, D
Publicado em 2006

Safety of ultrasound-guided central venous access in critically ill patients with uncorrected coagulopathy

Por Reusz, G, Langer, C, Egervari, G, Sarkany, P, Csomos, A
Publicado em 2013

Antigenic analysis of woodchuck hepatitis virus surface antigen with site-specific radioimmunoassays.

Por Cote, P J, Engle, R E, Langer, C A, Ponzetto, A, Gerin, J L
Publicado em 1984

P14.06 MOBI-KIDS STUDY: EXPOSURE TO COMMUNICATION TECHNOLOGIES AND BRAIN TUMOUR RISK IN CHILDREN AND ADOLESCENTS

Por Maule, M.M., Cardis, E., Eastman Langer, C., Sadetzki, S., Filippini, G., Farinotti, M., Miligi, L., Mattioli, S., Merletti, F.
Publicado em 2014

Two-stage hepatectomy (R0) with portal vein ligation—towards curing patients with extended bilobular colorectal liver metastases

Por Homayounfar, K., Liersch, T., Schuetze, G., Niessner, M., Goralczyk, A., Meller, J., Langer, C., Ghadimi, B. M., Becker, H., Lorf, T.
Publicado em 2008

Survival, quality-adjusted survival, and other clinical end points in older advanced non-small-cell lung cancer patients treated with albumin-bound paclitaxel

Por Langer, C J, Hirsh, V, Okamoto, I, Lin, F-J, Wan, Y, Whiting, S, Ong, T J, Renschler, M F, Botteman, M F
Publicado no Br J Cancer (2015)

Multiple myeloma is affected by multiple and heterogeneous somatic mutations in adhesion- and receptor tyrosine kinase signaling molecules

Por Leich, E, Weißbach, S, Klein, H-U, Grieb, T, Pischimarov, J, Stühmer, T, Chatterjee, M, Steinbrunn, T, Langer, C, Eilers, M, Knop, S, Einsele, H, Bargou, R, Rosenwald, A
Publicado em 2013

The feed-forward loop between YB-1 and MYC is essential for multiple myeloma cell survival

Por Bommert, KS, Effenberger, M, Leich, E, Küspert, M, Murphy, D, Langer, C, Moll, R, Janz, S, Mottok, A, Weissbach, S, Rosenwald, A, Bargou, R, Bommert, K
Publicado em 2012

Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab

Por Gualberto, A, Hixon, M L, Karp, D D, Li, D, Green, S, Dolled-Filhart, M, Paz-Ares, L G, Novello, S, Blakely, J, Langer, C J, Pollak, M N
Publicado em 2011

Differential effect of age on survival in advanced NSCLC in women versus men: Analysis of recent Eastern Cooperative Oncology Group (ECOG) studies, with and without bevacizumab

Por Wakelee, H.A., Dahlberg, S.E., Brahmer, J.R., Schiller, J.H., Perry, M.C., Langer, C.J., Sandler, A.B., Belani, C.P., Johnson, D.H.
Publicado em 2012

Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab

Por Gualberto, A, Hixon, M L, Karp, D D, Li, D, Green, S, Dolled-Filhart, M, Paz-Ares, L G, Novello, S, Blakely, J, Langer, C J, Pollak, M N
Publicado em 2012

Mutational landscape reflects the biological continuum of plasma cell dyscrasias

Por Rossi, A, Voigtlaender, M, Janjetovic, S, Thiele, B, Alawi, M, März, M, Brandt, A, Hansen, T, Radloff, J, Schön, G, Hegenbart, U, Schönland, S, Langer, C, Bokemeyer, C, Binder, M
Publicado no Blood Cancer J (2017)

A Phase I Trial of the HIV Protease Inhibitor Nelfinavir with Concurrent Chemoradiotherapy (CT-RT) for Unresectable Stage IIIA/IIIB NSCLC: A Report of Toxicities and Clinical Respo...

Por Rengan, R., Mick, R., Pryma, D., Rosen, M.A., Lin, L., Maity, A., Evans, T. L., Stevenson, J. P., Langer, C.J., Kucharczuk, J., Friedberg, J., Prendergast, S., Sharkoski, T., Hahn, S.M.
Publicado em 2012

Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M(3)P)

Por Kortüm, KM, Langer, C, Monge, J, Bruins, L, Zhu, YX, Shi, CX, Jedlowski, P, Egan, JB, Ojha, J, Bullinger, L, Kull, M, Ahmann, G, Rasche, L, Knop, S, Fonseca, R, Einsele, H, Stewart, AK, Braggio, Esteban
Publicado no Ann Hematol (2015)

Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer

Por Jonker, D J, Karapetis, C S, Harbison, C, O'Callaghan, C J, Tu, D, Simes, R J, Malone, D P, Langer, C, Tebbutt, N, Price, T J, Shapiro, J, Siu, L L, Wong, R P W, Bjarnason, G, Moore, M J, Zalcberg, J R, Khambata-Ford, S
Publicado em 2014

Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer

Por Bonomi, P D, Gandara, D, Hirsch, F R, Kerr, K M, Obasaju, C, Paz-Ares, L, Bellomo, C, Bradley, J D, Bunn Jr, P A, Culligan, M, Jett, J R, Kim, E S, Langer, C J, Natale, R B, Novello, S, Pérol, M, Ramalingam, S S, Reck, M, Reynolds, C H, Smit, E F, Socinski, M A, Spigel, D R, Vansteenkiste, J F, Wakelee, H, Thatcher, N
Publicado no Ann Oncol (2018)

Assessing the effect of obesity-related traits on multiple myeloma using a Mendelian randomisation approach

Por Went, M, Sud, A, Law, P J, Johnson, D C, Weinhold, N, Försti, A, van Duin, M, Mitchell, J S, Chen, B, Kuiper, R, Stephens, O W, Bertsch, U, Campo, C, Einsele, H, Gregory, W M, Henrion, M, Hillengass, J, Hoffmann, P, Jackson, G H, Lenive, O, Nickel, J, Nöthen, M M, da Silva Filho, M I, Thomsen, H, Walker, B A, Broyl, A, Davies, F E, Langer, C, Hansson, M, Kaiser, M, Sonneveld, P, Goldschmidt, H, Hemminki, K, Nilsson, B, Morgan, G J, Houlston, R S
Publicado no Blood Cancer J (2017)